Department of Dermatology, University of California, Davis, Sacramento, 95816, USA.
Am J Surg. 2013 Sep;206(3):410-7. doi: 10.1016/j.amjsurg.2012.11.018. Epub 2013 Jun 4.
Determining whether systemic corticosteroids impair wound healing is a clinically relevant topic that has important management implications.
We reviewed literature on the effects of corticosteroids on wound healing from animal and human studies searching MEDLINE from 1949 to 2011.
Some animal studies show a 30% reduction in wound tensile strength with perioperative corticosteroids at 15 to 40 mg/kg/day. The preponderance of human literature found that high-dose corticosteroid administration for <10 days has no clinically important effect on wound healing. In patients taking chronic corticosteroids for at least 30 days before surgery, their rates of wound complications may be increased 2 to 5 times compared with those not taking corticosteroids. Complication rates may vary depending on dose and duration of steroid use, comorbidities, and types of surgery.
Acute, high-dose systemic corticosteroid use likely has no clinically significant effect on wound healing, whereas chronic systemic steroids may impair wound healing in susceptible individuals.
判断全身性皮质类固醇是否会影响伤口愈合是一个具有重要管理意义的临床相关问题。
我们检索了 1949 年至 2011 年 MEDLINE 中关于皮质类固醇对伤口愈合影响的动物和人体研究文献。
一些动物研究表明,在 15 至 40mg/kg/天的围手术期使用皮质类固醇会使伤口的拉伸强度降低 30%。大多数人体文献发现,接受 10 天以内的高剂量皮质类固醇治疗对伤口愈合没有明显的临床影响。在术前至少 30 天开始服用慢性皮质类固醇的患者中,其伤口并发症的发生率可能比未服用皮质类固醇的患者增加 2 至 5 倍。并发症的发生率可能取决于皮质类固醇的剂量和使用时间、合并症以及手术类型。
急性、大剂量全身性皮质类固醇的使用可能对伤口愈合没有明显的临床影响,而慢性全身性皮质类固醇可能会使易受影响的个体的伤口愈合受到损害。